Nicotine Dependence Clinical Trial
Official title:
Incentives to Promote Smoking Cessation in Low SES Women
The purpose of this study is to investigate the feasibility of a mobile-phone based
contingency management (CM) intervention for smoking in low-SES women. The CM intervention
will be combined with a Brief Motivational Interviewing (BMI) counseling component. This
study will examine the following research aims:
Primary Aim: To compare the effects of a Brief Motivational Intervention (BMI) + mobile
phone-based CM on tobacco use when compared to BMI with a non-contingent control condition in
a small feasibility trial.
Hypothesis: The investigators expect women in the BMI + CM condition to have more smoke free
days than women in the BMI + NC condition.
Secondary Aim: To examine alcohol use as a moderator of cessation outcomes.
Cigarette smoking is the leading cause of preventable death in the United States, accounting
for one out of every five deaths (CDC, 2012). In particular, smoking prevalence rates are
high among socioeconomically-disadvantaged women; for example, over 40% of women with less
than 12 yrs education smoke, compared to 28% and 16% among those with some college and
undergraduate degrees (SAMHSA, 2010). Smoking cessation rates are particularly low among
low-SES women with co-occurring alcohol use disorders, and these substances are frequently
used together (Kahler et al., 2010; Businelle et al., 2013). Therefore, interventions that
reduce both alcohol and smoking among heavy alcohol-using women are vitally needed to reduce
rates of smoking-related morbidity and mortality in this vulnerable population.
Counseling approaches that incorporate problem solving, skills training and social support
are effective for reducing smoking in the general population (Fiore et al., 2008). However,
given the high rates of smoking among alcohol-using women, they may be inadequate for in this
population. Contingency management (CM) interventions, which provide tangible reinforcers
contingent upon smoking abstinence or reduction to a criterion level, are highly-efficacious
interventions for reducing cigarette smoking and other drug use in low-SES women (Higgins et
al., 2012). Within the theoretical framework of operant conditioning, increasing the
availability of an alternative reinforcer weakens the amount of control that the drug has
over the user's behavior, especially when obtaining the alternative reinforcer is contingent
on behaviors incompatible with drug use (Higgins, 1997). The tenets of CM interventions
include (1) arranging the environment such that the target behavior can be readily and
objectively detected, (2) providing a tangible reinforcer when the target behavior occurs,
and (3) withholding reinforcement when the target behavior does not occur (Higgins et al.,
1994).
Although CM interventions clearly are effective at promoting smoking reductions, there are
several challenges associated with translating CM into an effective clinical treatment for
smoking. Perhaps the most significant challenge is the frequent monitoring necessary to
objectively verify smoking abstinence using breath carbon monoxide (CO), the most convenient
objective measure of smoking status. Because of the short half-life of CO (5-6 hours), CO
levels must be measured at least twice per day in order to verify continuous abstinence.
Recent CM-smoking studies have addressed this feasibility challenge by providing study
participants with breath CO monitors and laptop computers or smartphones to use in their own
natural environments (e.g., Dallery, Raiff & Grabinski, 2013). Participants are taught how to
use their smartphones to text videos of themselves providing a breath CO level to a research
staff member, twice per day. After the study staff has determined that the breath CO sample
meets the abstinence criterion, participants are informed of the amount that they have earned
for that sample.
Given the high rates of smoking in low-SES women, investigating the additive impact of an
in-person brief counseling intervention and a phone-based CM intervention is an important
next step in examining effective methods to reduce the impact of smoking in this population.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05176418 -
IV Pulsed-Nicotine as a Model of Smoking: The Effects of Dose and Delivery Rate
|
Early Phase 1 | |
Completed |
NCT04084210 -
Impact of Alternative Nicotine-Delivery Products on Combustible Cigarette Use
|
Phase 2 | |
Completed |
NCT04043728 -
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
|
N/A | |
Withdrawn |
NCT03707600 -
State and Trait Mediated Response to TMS in Substance Use Disorder
|
N/A | |
Recruiting |
NCT03999099 -
Targeting Orexin to Treat Nicotine Dependence
|
Phase 1 | |
Completed |
NCT03847155 -
Prevention of Nicotine Abstinence in Critically Ill Patients After Major Surgery
|
N/A | |
Completed |
NCT02840435 -
Study on Sit to Quit Phone Intervention
|
N/A | |
Completed |
NCT02139930 -
Project 2: Strategies for Reducing Nicotine Content in Cigarettes
|
N/A | |
Completed |
NCT01982110 -
A Mindfulness Based Application for Smoking Cessation
|
N/A | |
Completed |
NCT01926626 -
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
|
Phase 2 | |
Completed |
NCT01569490 -
Striving to Quit: First Breath
|
N/A | |
Withdrawn |
NCT01569477 -
Striving to Quit-Wisconsin Tobacco Quit Line
|
N/A | |
Completed |
NCT01685996 -
Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation
|
Phase 1/Phase 2 | |
Completed |
NCT01632189 -
The Effect of Varenicline on D2/D3 Receptor Binding in Smokers
|
N/A | |
Active, not recruiting |
NCT01182766 -
New Treatment for Alcohol and Nicotine Dependence
|
Phase 2/Phase 3 | |
Completed |
NCT00996034 -
Nicotine Vaccination and Nicotinic Receptor Occupancy
|
Phase 2 | |
Completed |
NCT01061528 -
Coping Skills Treatment for Smoking Cessation
|
N/A | |
Suspended |
NCT01636336 -
Effects of Progesterone on Smoked Nicotine Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effects
|
N/A | |
Completed |
NCT01943994 -
Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study
|
N/A | |
Withdrawn |
NCT01589081 -
Effects of Progesterone on IV Nicotine-Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effect
|
N/A |